Skip to main content

Advertisement

ADVERTISEMENT

Medication Treatments

News
01/17/2019
The Food and Drug Administration (FDA) has tested and released model labeling language that would guide consumers in using over-the-counter formulations of the opioid overdose reversal drug.
The Food and Drug Administration (FDA) has tested and released model labeling language that would guide consumers in using over-the-counter formulations of the opioid overdose reversal drug.
The Food and Drug Administration...
01/17/2019
Addiction Professional
01/17/2019
A study reveals that drug testing can serve as an important guide to outpatient treatment at stages where patients may be reluctant to self-report use.
A study reveals that drug testing can serve as an important guide to outpatient treatment at stages where patients may be reluctant to self-report use.
A study reveals that drug...
01/17/2019
Addiction Professional
News
01/14/2019
Life of Purpose Addiction Treatment Centers is also initiating pharmacogenetic testing and maintenance dosing of medication-assisted treatment into its clinical operations.
Life of Purpose Addiction Treatment Centers is also initiating pharmacogenetic testing and maintenance dosing of medication-assisted treatment into its clinical operations.
Life of Purpose Addiction...
01/14/2019
Addiction Professional
News
01/02/2019
A study sought to validate an opioid overdose patient discharge rule established in 2000.
A study sought to validate an opioid overdose patient discharge rule established in 2000.
A study sought to validate an...
01/02/2019
Addiction Professional
News
12/31/2018
An independent analysis places the buprenorphine-naloxone combination second to a blood pressure medication among the most prescribed medications in the state of Maine.
An independent analysis places the buprenorphine-naloxone combination second to a blood pressure medication among the most prescribed medications in the state of Maine.
An independent analysis places...
12/31/2018
Addiction Professional
12/24/2018
Leaders at Boston Medical Center decry regulations and biases that impede access to the most evidence-based interventions for opioid use disorders.
Leaders at Boston Medical Center decry regulations and biases that impede access to the most evidence-based interventions for opioid use disorders.
Leaders at Boston Medical Center...
12/24/2018
Addiction Professional
News
12/19/2018
Research found that the reSET-O app improved retention in treatment for opioid use disorder patients receiving buprenorphine and behavioral therapy.
Research found that the reSET-O app improved retention in treatment for opioid use disorder patients receiving buprenorphine and behavioral therapy.
Research found that the reSET-O...
12/19/2018
Addiction Professional
News
12/05/2018
Results of a study suggest the need to warn drug-naive patients of the potential effects of methadone and buprenorphine on driving performance.
Results of a study suggest the need to warn drug-naive patients of the potential effects of methadone and buprenorphine on driving performance.
Results of a study suggest the...
12/05/2018
Addiction Professional
12/03/2018
Some advocates see a preliminary injunction in a case involving a methadone patient facing jail time as a landmark moment for expanding medication-assisted treatment in corrections.
Some advocates see a preliminary injunction in a case involving a methadone patient facing jail time as a landmark moment for expanding medication-assisted treatment in corrections.
Some advocates see a preliminary...
12/03/2018
Addiction Professional
11/12/2018
A University of Kentucky researcher cited challenges that slow the process of discovering viable medication options for treating cocaine dependence.
A University of Kentucky researcher cited challenges that slow the process of discovering viable medication options for treating cocaine dependence.
A University of Kentucky...
11/12/2018
Addiction Professional

Advertisement

Advertisement